Harshad Ladha
Overview
Explore the profile of Harshad Ladha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramaswamy V, Hielscher T, Mack S, Lassaletta A, Lin T, Pajtler K, et al.
J Clin Oncol
. 2016 Jun;
34(21):2468-77.
PMID: 27269943
Purpose: Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a distinct biology and natural history. The therapeutic value of cytoreductive surgery and radiation therapy...
2.
Krishna S, Bhattacharya A, Li F, Ross W, Ladha H, Porter K, et al.
Pancreas
. 2015 Sep;
45(3):394-400.
PMID: 26418912
Objectives: To identify factors differentiating pancreatic neuroendocrine tumors (PNETs) from non-PNET neoplastic solid pancreatic lesions (SPLs) and assess the accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). Methods: This is a...
3.
Ladha H, Pawar T, Gilbert M, Mandel J, O-Brien B, Conrad C, et al.
J Neurooncol
. 2015 Aug;
124(3):501-6.
PMID: 26298437
Bevacizumab (BEV) is commonly used for treating recurrent glioblastoma (GBM), and wound healing is a well-established adverse event. Retrospective analysis of GBM patients with and without wound healing complications while...
4.
Armstrong T, Vera-Bolanos E, Acquaye A, Gilbert M, Ladha H, Mendoza T
Neuro Oncol
. 2015 Aug;
18(2):252-60.
PMID: 26289592
Background: A set of symptoms common across cancers has been proposed to enhance quality of care and clinical research in solid tumor patients. Using data from several clinical studies, this...
5.
Krishna S, Bhattacharya A, Ross W, Ladha H, Porter K, Bhutani M, et al.
J Gastroenterol Hepatol
. 2015 Apr;
30(10):1552-60.
PMID: 25867963
Background And Aim: Early diagnosis of solid pancreatic lesions (SPLs) enables prompt treatment. The study aims to identify factors differentiating metastatic lesion to the pancreas (PMET) from pancreatic ductal adenocarcinoma...
6.
Krishna S, Li F, Bhattacharya A, Ladha H, Porter K, Singh A, et al.
Gastrointest Endosc
. 2014 Dec;
81(2):370-9.
PMID: 25442085
Background: Pancreatic ductal adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (pNET), and metastatic lesions (pMET) are the most common neoplastic solid pancreatic lesions (SPLs). Early diagnosis enables prompt treatment. Objective: To identify...
7.
Ganeshan D, Morani A, Ladha H, Bathala T, Kang H, Gupta S, et al.
Abdom Imaging
. 2013 Oct;
39(1):66-85.
PMID: 24077815
Renal cell carcinoma is the most common malignant renal tumor in the adults. Significant advances have been made in the management of localized and advanced renal cell carcinoma. Surgery is...